Citadel Advisors
GHSI

Citadel Advisors’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Citadel Advisors’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-937
Closed -$6.8K – 15716
2022
Q4 		$6.8K Buy
+937
New +$7.5K ﹤0.01% 13881
2022
Q3 		– Sell
-693
Closed -$5K – 13835
2022
Q2 		$5K Sell
693
-646
-48% -$5.65K ﹤0.01% 12680
2022
Q1 		$16K Buy
1,339
+1,128
+535% +$22.9K ﹤0.01% 13302
2021
Q4 		$7K Sell
211
-128
-38% -$6.87K ﹤0.01% 13684
2021
Q3 		$21K Sell
339
-165
-33% -$11K ﹤0.01% 13639
2021
Q2 		$44K Sell
504
-550
-52% -$47.8K ﹤0.01% 13382
2021
Q1 		$126K Sell
1,054
-41
-4% -$8.27K ﹤0.01% 12245
2020
Q4 		$136K Sell
1,095
-46
-4% -$3.21K ﹤0.01% 10008
2020
Q3 		$69K Buy
1,141
+1,025
+884% +$106K ﹤0.01% 9473
2020
Q2 		$15K Buy
116
+73
+170% +$10.2K ﹤0.01% 9595
2020
Q1 		$6K Buy
+43
New +$4.55K ﹤0.01% 9476
2019
Q3 		– Sell
-38
Closed -$14K – 9877
2019
Q2 		$14K Buy
+38
New +$22.4K ﹤0.01% 8995

Other funds holding GHSI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's GHSI Position: Q1 2023 in Review

Citadel Advisors sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q1 2023, closing a stake of 937 shares — an estimated $6.8K sold.

Citadel Advisors first reported a position in GHSI in Q2 2019 and held it in 12 quarters. The position peaked at $136K in Q4 2020. 10 funds tracked by Wall St. Rank hold GHSI as of Q1 2023.

  • Citadel Advisors reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 937 Guardion Health Sciences, Inc. Common Stock shares in Q1 2023, an estimated $6.8K.
  • Citadel Advisors first reported a position in Guardion Health Sciences, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
  • Citadel Advisors's Guardion Health Sciences, Inc. Common Stock position peaked at $136K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.